Salve Therapeutics, Inc. — Form D

Salve Therapeutics, Inc. of SAN PEDRO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-02. The offering totals $688K, of which $13K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-05-02
• Form: D
• Accession: 0002065545-25-000001
• Industry: Biotechnology
• Exemptions: 06c
• Total offering: $688K
• Amount sold: $13K
• Remaining: $675K
• Minimum investment: $2K
• Investors: 3
• Date of first sale: 2024-06-10
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-545076

Issuer

• Name: Salve Therapeutics, Inc.
• CIK: 0002065545
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2022
• Address: 461 W 6TH ST, SAN PEDRO, CA, 90731
• Phone: 6178944338

Officers, directors & promoters (1)

More

• CIK 2065545 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search